Literature DB >> 27588262

Phosphorylation of alphaB-crystallin in epiretinal membrane of human proliferative diabetic retinopathy.

Yoko Dong1, Zhenyu Dong1, Satoru Kase1, Ryo Ando1, Junichi Fukuhara1, Satoshi Kinoshita1, Saori Inafuku1, Yoshiaki Tagawa1, Erdal Tan Ishizuka1, Wataru Saito1, Miyuki Murata1, Atsuhiro Kanda1, Kousuke Noda1, Susumu Ishida1.   

Abstract

AIM: To examine phosphorylation of alphaB-crystallin (p-αBC), a vascular endothelial growth factor (VEGF) chaperone, and immunohistochemically investigate relationship between p-αBC, VEGF and phosphorylated p38-mitogen-activated protein kinase (p-p38 MAPK) in the epiretinal membrane of human proliferative diabetic retinopathy (PDR).
METHODS: Eleven epiretinal membranes of PDR surgically excised were included in this study. Two normal retinas were also collected from enucleation tissues due to choroidal melanoma. Paraformaldehyde-fixed, paraffin-embedded tissue sections were processed for immunohistochemistry with anti-p-αBC, VEGF, CD31, and p-p38 MAPK antibodies.
RESULTS: Immunoreactivity for p-αBC was observed in all of the epiretinal membranes examined, where phosphorylation on serine (Ser) 59 showed strongest immunoreactivity in over 70% of the membranes. The immunolocalization of p-αBC was detected in the CD31-positive endothelial cells, and co-localized with VEGF and p-p38 MAPK in PDR membranes. Immunoreactivity for p-αBC, however, was undetectable in endothelial cells of the normal retinas, where p-p38 MAPK immunoreactivity was less marked than PDR membranes.
CONCLUSION: Phosphorylation of αBC, in particular, phosphorylation on Ser59 by p-p38 MAPK may play a potential role as a molecular chaperon for VEGF in the pathogenesis of epiretinal membranes in PDR.

Entities:  

Keywords:  neovascularization; phosphorylated alphaB-crystallin; proliferative diabetic retinopathy; vascular endothelial growth factor

Year:  2016        PMID: 27588262      PMCID: PMC4990572          DOI: 10.18240/ijo.2016.08.03

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  25 in total

1.  Angiogenic pathways in diabetic retinopathy.

Authors:  Lloyd Paul Aiello
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

2.  Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes.

Authors:  Ahmed M Abu El-Asrar; Luc Missotten; Karel Geboes
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

Review 3.  Lens crystallins: the evolution and expression of proteins for a highly specialized tissue.

Authors:  G J Wistow; J Piatigorsky
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Response of small heat shock proteins in diabetic rat retina.

Authors:  Vadde Sudhakar Reddy; Ganugula Raghu; Singareddy Sreenivasa Reddy; Anil Kumar Pasupulati; Palla Suryanarayana; Geereddy Bhanuprakash Reddy
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-19       Impact factor: 4.799

5.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

6.  Expression of heat shock protein 27 and alpha-crystallins in human retinoblastoma after chemoreduction.

Authors:  S Kase; J G Parikh; N A Rao
Journal:  Br J Ophthalmol       Date:  2008-09-23       Impact factor: 4.638

7.  Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function.

Authors:  Yunpeng Du; Jie Tang; Guangyuan Li; Guanyuan Li; Liliana Berti-Mattera; Chieh Allen Lee; Darian Bartkowski; David Gale; Joe Monahan; Michael R Niesman; Gordon Alton; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-13       Impact factor: 4.799

Review 8.  Overview of epidemiologic studies of diabetic retinopathy.

Authors:  Barbara Eden Kobrin Klein
Journal:  Ophthalmic Epidemiol       Date:  2007 Jul-Aug       Impact factor: 1.648

9.  alphaB-crystallin: a novel p53-target gene required for p53-dependent apoptosis.

Authors:  Gou Watanabe; Shunsuke Kato; Hideyuki Nakata; Takanori Ishida; Noriaki Ohuchi; Chikashi Ishioka
Journal:  Cancer Sci       Date:  2009-08-18       Impact factor: 6.716

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  3 in total

1.  Serum advanced glycation end-products and αB-crystallin in diabetic retinopathy patients.

Authors:  Taku Yamamoto; Satoru Kase; Miyuki Murata; Susumu Ishida
Journal:  Biomed Rep       Date:  2022-02-18

Review 2.  Small Heat Shock Proteins in Retinal Diseases.

Authors:  Vivian Rajeswaren; Jeffrey O Wong; Dana Yabroudi; Rooban B Nahomi; Johanna Rankenberg; Mi-Hyun Nam; Ram H Nagaraj
Journal:  Front Mol Biosci       Date:  2022-04-11

3.  Loss of αA or αB-Crystallin Accelerates Photoreceptor Cell Death in a Mouse Model of P23H Autosomal Dominant Retinitis Pigmentosa.

Authors:  Tiantian Wang; Jingyu Yao; Lin Jia; Patrice E Fort; David N Zacks
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.